蘭州大學(xué)

2025/2026考研輔導(dǎo)網(wǎng)課

中國(guó)考研網(wǎng) 考研網(wǎng) » 院校信息 » 蘭州大學(xué) » 研究生導(dǎo)師介紹

蘭州大學(xué)基礎(chǔ)醫(yī)學(xué)院導(dǎo)師介紹：譚繼英

分類(lèi)：導(dǎo)師信息來(lái)源：中國(guó)考研網(wǎng) 2015-07-28　相關(guān)院校：蘭州大學(xué)

2025考研數(shù)學(xué)全程班早鳥(niǎo)3班

26考研全科上岸規(guī)劃營(yíng)「擇校▪規(guī)劃▪備考」

蘭州大學(xué)2025考研專(zhuān)業(yè)課復(fù)習(xí)資料「真題▪筆記▪講義▪題庫(kù)」

姓名：譚繼英
Name Tan, Jiying
職務(wù)：教授（四級(jí)），碩士生導(dǎo)師
Duty Professor
專(zhuān)業(yè)：免疫學(xué)、循證醫(yī)學(xué)
Major Immunology & Evidence Based Medicine
E-mail: tanjy@lzu.edu.cn

一、科研方向

1. HIV感染免疫細(xì)胞相關(guān)分子機(jī)制和HIV潛伏感染；
2. 結(jié)核疫苗和結(jié)核免疫
3. 基于HIV和結(jié)核病相關(guān)的循證醫(yī)學(xué)與免疫學(xué)研究；
Research Interests：
1.   The Molecular mechanisms of HIV infect Immnuocytes & HIV latent infection
2.   The Vaccine of Tuberculosis & Immune of Tuberculosis
3.   Evidence Based Medicine & Immunology of HIV and Tuberculosis

二、個(gè)人簡(jiǎn)歷

1. 2011年6月至2014年3月在美國(guó)食品藥品管理局（Food and Drug of Administration, FDA）生
物安全評(píng)價(jià)中心（Center for Biologics Evaluation and Research, CBER）分子病毒學(xué)研究室（Laboratory of Molecular Virology, LMV）博士后，主要從事HIV的分子免疫學(xué)機(jī)理的研究。
2. 2003年12月至2014年4月蘭州大學(xué)免疫學(xué)研究所副教授。
3. 2006年6月在四川大學(xué)華西臨床醫(yī)學(xué)院外科學(xué)專(zhuān)業(yè)移植免疫和循證醫(yī)學(xué)方向獲得博士學(xué)位。
Resume：
1.    Postdoc   May 2011 – March 2014
Lab. of Molecular virology (LMV), Center for Biologics Evaluation and Research,
(CBER), Food and Drug of Administration, (FDA).   My researches are to study on effects of host factors on HIV-1 replication and reactivation from its latent infection:
Key contribution:
Determined the mechanisms by which HIV-1 induces infected cell death;
Found the effects of molecules from apoptotic/autophagy pathways on HIV-1 replication;
--Some mechanisms of FLIP expression in HIV-1 replication,
--The effects of FADD knockdown on HIV-1 replication,
--Mechanisms of XIAP in HIV-1-induced cell death and HIV-1 replication,
Understand the effects of 2009 pandemic influenza H1N1 virus infection on HIV-1 infection,
replication and reactivation from HIV-1 latent infection.
2. Associated Professor Dec. 2003 - May 2011
Dept. of Immunology, School of Basic Medical Sciences, Lanzhou University
My researched fields were vaccine of Tuberculosis. The fund from Ministry of Health of CHINA to Study of pre-Clinic of Tuberculosis subunit vaccines.
3. Ph.D. Candidate    Sep. 2003 - Jun. 2006
Key Laboratory of Transplant Engineering and Immunology, and Ministry of Health, and Chinese Centre of Evidence–Based Medicine, West China Hospital, West china medical school, Sichuan University, Chengdu 610041, CHINA. My researches were experiment of immunotolerance and review of infection after renal transplantation.

三、主要科研信息

（一）參與合作的主要課題：
1.   參加FDA的項(xiàng)目：NHLBI 13， To test and compare HIV from Cameroon in diagnosis and pathology;
2.   參加FDA的項(xiàng)目： NHLBI 13，To test and diagnosis using new technology
3.   國(guó)家科技重大研究專(zhuān)項(xiàng)（2012ZX10003-008-006）， “結(jié)核病創(chuàng)新型疫苗的研制”子課題“結(jié)核病免疫加強(qiáng)用亞單位疫苗臨床前研究”，子課題下部分研究。
4.   中央高�；究蒲袠I(yè)務(wù)費(fèi)專(zhuān)項(xiàng)資金, 蘭州大學(xué)重點(diǎn)項(xiàng)目: 結(jié)核分枝桿菌主要流行菌株致病機(jī)制與疫苗研究。（lzujbky-2010-k07），主持子項(xiàng)。
5.   國(guó)家科技重大研究專(zhuān)項(xiàng)（2008ZX10003011），“結(jié)核分枝桿菌感染的免疫保護(hù)機(jī)制”子課題“結(jié)核免疫病理分子機(jī)制”，子課題下部分研究。
6.   甘肅省鄉(xiāng)鎮(zhèn)衛(wèi)生院繼續(xù)教育群隨機(jī)實(shí)驗(yàn):CMB項(xiàng)目（CBM09-944）

（二）主要文章（Publication）
1.    Jiying Tan, Xue Wang*, Krishnakumar Devadas, Jiangqin Zhao, Panhe Zhang, Indira Hewlett*.   Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs. J Cell Physiol. 2013: 228 (12): 2305-13
2.    Xue Wang*, Jiying Tan, Jiangqin Zhao, Viswannath Ragupathy, Mohan Haleyurgirisetty , Indira Hewlett*. Some findings of FADD knockdown in inhibition of HIV-1 replication in Jurkat cells and PBMCs. Mol Cell Biochem, 2014; 393 (1-2):181-90. (共同第一)
3.    Xue Wang *, Jiying Tan, Olga Zouev , Jiangqin Zhao, Zhiping Ye, Indira Hewlett*. Novel pandemic influenza A (H1N1) virus infection modulates apoptotic pathways that impact its replication in A549 cells. Microbes Infect. 2014;16 (3): 178-86. (共同第一)
4.    Xue Wang* , Yamei Gao, Jiying Tan, Krishnakumar Devadas, Viswanath Ragupathy, Kazuyo Takeda, Jiangqin Zhao, Indira Hewlett*. HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells. Cellular Signaling 2012; 24 1414–1419
5.    Tan JY, Li SH, Yang KH,. Ustekinumab，a human interleukin-12/23 monoclonal antibody，in patients with psoriasis: A meta-analysis. Journal of Dermatological treatment. 2011; 22: 323–336
6.    謝富佳，譚繼英（通訊作者）*，喬梅，梁正羽，王世婷，唐克峰，祝秉東，楊燕，章國(guó)平. CFP21-ELISPOT方法的建立及其在結(jié)核分枝桿菌感染診斷中的應(yīng)用. 中國(guó)病原生物學(xué)雜志2011,6(9): 647-683
7.    謝富佳，譚繼英（通訊作者）*，梁正羽，喬梅，祝秉東，吳玉敏，楊燕，章國(guó)平. 結(jié)核分枝桿菌培養(yǎng)濾液蛋白21(CFP21)的基因克隆、表達(dá)及純化. 中國(guó)人獸共患病學(xué)報(bào). 2011,27(2): 117-119
8.    吳玉敏, 譚繼英（通訊作者）*，王革，劉萬(wàn)波，胡麗娜，祝秉東. 核分枝桿菌Mtb8. 4- spx 和Hspx-Mtb8. 4重組基因克隆及表達(dá). 中國(guó)病原生物學(xué)雜志. 2010；6（5）：414-417
9.    李少紅，馬彬，譚繼英（通訊作者）*，楊克虎. 依那西普治療強(qiáng)直性脊柱炎的系統(tǒng)評(píng)價(jià). 中國(guó)循證醫(yī)學(xué)雜志. 2009, 9(4): 423-429
10. 安睿曉，田金徽，譚繼英（通訊作者）*, 楊克虎. 環(huán)磷酰胺聯(lián)合靜脈注射免疫球蛋白治療系統(tǒng)性紅斑狼瘡的系統(tǒng)評(píng)價(jià)等. 中國(guó)循證醫(yī)學(xué)雜志，2011, 11(3): 320-324
11. JY. Tan, N. Zhao, Y.P. Li*. Steroid Withdrawal Increases Risk of Acute Rejection But Reduces Infection：A System Review in Renal Transplantation. Transplantation proceedings 2006 Sep;38(7):2054-6 (The 9th Congress of Asian Society of Transplantation. Oral）